Opinion
Video
A medical professional examines the pivotal roles of molecular profiling, next-generation sequencing, and germline testing in guiding treatment decisions for ovarian cancer.
Dr Yehuda Handelsman on How DCRM 2.0 Guidelines Refine CRM Disease Management
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Top 5 Most-Read Articles on Rare Blood Disorders in 2024
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
Further Refining the Myasthenia Gravis Continuum
ICYMI: Highlights From CHEST 2024